Table 3.
Background of patients enrolled in this study at follow up.
| At follow up | Responder | Non-responder | p value | N | |
|---|---|---|---|---|---|
| Echocardiogram | LVDd (mm) | 49.0 ± 7.7 | 59.3 ± 8.3 | 0.008 | 14.8 |
| LVDs (mm) | 34.6 ± 8.5 | 50.6 ± 10.3 | 0.001 | 14.8 | |
| EF (%) | 57.2 ± 11.5 | 33.1 ± 12.9 | < 0.001 | 14.8 | |
| Lab | Cre (g/dL) | 2.6 ± 4.2 | 1.2 ± 0.5 | 0.409 | 13.6 |
| Hb (g/dL) | 13.4 ± 2.3 | 15.1 ± 1.6 | 0.115 | 13.6 | |
| BNP (pg/ml) | 150.3 ± 175.2 | 96.6 ± 73.2 | 0.494 | 9.6 | |
| Drugs | β blocker | 12 (100%) | 8 (100%) | NS | 12.8 |
| ACE-i/ARB | 9 (75%) | 8 (100%) | 0.125 | 12.8 | |
| spironolactone | 10 (83.3%) | 6 (75.0%) | 0.648 | 12.8 | |
| Diuretics | 9 (75%) | 7 (87.5%) | 0.494 | 12.8 | |
| amiodarone | 0 (0%) | 1 (12.5%) | 0.191 | 12.8 | |
Background of responders or non-responders at follow-up. Data were analyzed by two-tailed Student’s t-test, except for data for drugs. This data was analyzed by Chi-square test. Results are shown as mean ± SD.
NS not significant.